https://stock.noler.com/us/stock/statera-biopharma-inc https://stock.noler.com/us/stock/statera-biopharma-inc/accounts-payable https://stock.noler.com/us/stock/statera-biopharma-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/statera-biopharma-inc/accounts-receivable https://stock.noler.com/us/stock/statera-biopharma-inc/accrued-bonuses-current https://stock.noler.com/us/stock/statera-biopharma-inc/accrued-liabilities-current https://stock.noler.com/us/stock/statera-biopharma-inc/accumulated-depreciation https://stock.noler.com/us/stock/statera-biopharma-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/statera-biopharma-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/statera-biopharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/statera-biopharma-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/statera-biopharma-inc/adjustment-for-amortization https://stock.noler.com/us/stock/statera-biopharma-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/statera-biopharma-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/statera-biopharma-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/statera-biopharma-inc/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/statera-biopharma-inc/amended-reports-10-k https://stock.noler.com/us/stock/statera-biopharma-inc/amended-reports-10-q https://stock.noler.com/us/stock/statera-biopharma-inc/amortization https://stock.noler.com/us/stock/statera-biopharma-inc/amortization-of-deferred-charges https://stock.noler.com/us/stock/statera-biopharma-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/statera-biopharma-inc/aoci https://stock.noler.com/us/stock/statera-biopharma-inc/asset-impairment-charges https://stock.noler.com/us/stock/statera-biopharma-inc/asset-management-costs https://stock.noler.com/us/stock/statera-biopharma-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/statera-biopharma-inc/basic-shares https://stock.noler.com/us/stock/statera-biopharma-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/statera-biopharma-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/statera-biopharma-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/statera-biopharma-inc/capital-expenditures https://stock.noler.com/us/stock/statera-biopharma-inc/capital-lease-obligations https://stock.noler.com/us/stock/statera-biopharma-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/statera-biopharma-inc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/statera-biopharma-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/statera-biopharma-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/statera-biopharma-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/statera-biopharma-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/statera-biopharma-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/statera-biopharma-inc/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/statera-biopharma-inc/capital-leases-lessee-balance-sheet-assets-by-major-class-accumulated-deprecation https://stock.noler.com/us/stock/statera-biopharma-inc/cash https://stock.noler.com/us/stock/statera-biopharma-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/statera-biopharma-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/statera-biopharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/statera-biopharma-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/statera-biopharma-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/statera-biopharma-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/statera-biopharma-inc/cash-divested-from-deconsolidation https://stock.noler.com/us/stock/statera-biopharma-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/statera-biopharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/statera-biopharma-inc/cash-uninsured-amount https://stock.noler.com/us/stock/statera-biopharma-inc/change-in-unrealized-gain-loss-on-fair-value-hedging-instruments https://stock.noler.com/us/stock/statera-biopharma-inc/change-in-unrealized-gain-loss-on-fair-value-hedging-instruments-1 https://stock.noler.com/us/stock/statera-biopharma-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/statera-biopharma-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/statera-biopharma-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/statera-biopharma-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/statera-biopharma-inc/clinical-trials https://stock.noler.com/us/stock/statera-biopharma-inc/commitments-and-contingencies https://stock.noler.com/us/stock/statera-biopharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/statera-biopharma-inc/common-stock-value https://stock.noler.com/us/stock/statera-biopharma-inc/comprehensive-income https://stock.noler.com/us/stock/statera-biopharma-inc/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/statera-biopharma-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/statera-biopharma-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/statera-biopharma-inc/consolidation-less-than-wholly-owned-subsidiary-parent-ownership-interest-change-due-to-net-income-attributable-to-parent-and-effects-of-changes-net https://stock.noler.com/us/stock/statera-biopharma-inc/contract-liability https://stock.noler.com/us/stock/statera-biopharma-inc/contract-with-customer-asset-net-current https://stock.noler.com/us/stock/statera-biopharma-inc/contract-with-customer-asset-net-noncurrent https://stock.noler.com/us/stock/statera-biopharma-inc/contracts-revenue https://stock.noler.com/us/stock/statera-biopharma-inc/convertible-preferred-dividends-net-of-tax https://stock.noler.com/us/stock/statera-biopharma-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/statera-biopharma-inc/cost-of-revenue https://stock.noler.com/us/stock/statera-biopharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/statera-biopharma-inc/current-assets https://stock.noler.com/us/stock/statera-biopharma-inc/current-liabilities https://stock.noler.com/us/stock/statera-biopharma-inc/debt-annual-principal-payment https://stock.noler.com/us/stock/statera-biopharma-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/statera-biopharma-inc/debt-issued https://stock.noler.com/us/stock/statera-biopharma-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/statera-biopharma-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/statera-biopharma-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/statera-biopharma-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/statera-biopharma-inc/debt-periodic-payment https://stock.noler.com/us/stock/statera-biopharma-inc/debt-periodic-payment-interest https://stock.noler.com/us/stock/statera-biopharma-inc/debt-repaid https://stock.noler.com/us/stock/statera-biopharma-inc/deconsolidation-gain-or-loss-amount https://stock.noler.com/us/stock/statera-biopharma-inc/decrease-in-restricted-cash https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-costs https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-finance-costs-current-net https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-revenue https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-allowance-for-doubtful-accounts https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/statera-biopharma-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/statera-biopharma-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/statera-biopharma-inc/defined-contribution-plan-maximum-annual-contribution-per-employee-percent https://stock.noler.com/us/stock/statera-biopharma-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/statera-biopharma-inc/deposits https://stock.noler.com/us/stock/statera-biopharma-inc/deposits-assets-current https://stock.noler.com/us/stock/statera-biopharma-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/statera-biopharma-inc/depreciation https://stock.noler.com/us/stock/statera-biopharma-inc/depreciation-and-amortization https://stock.noler.com/us/stock/statera-biopharma-inc/derivative-liabilities https://stock.noler.com/us/stock/statera-biopharma-inc/derivative-liabilities-current https://stock.noler.com/us/stock/statera-biopharma-inc/diluted-shares https://stock.noler.com/us/stock/statera-biopharma-inc/dilutive-shares https://stock.noler.com/us/stock/statera-biopharma-inc/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/statera-biopharma-inc/dividends-preferred-stock https://stock.noler.com/us/stock/statera-biopharma-inc/due-from-joint-ventures-current https://stock.noler.com/us/stock/statera-biopharma-inc/due-from-related-parties-current https://stock.noler.com/us/stock/statera-biopharma-inc/due-to-related-parties-current https://stock.noler.com/us/stock/statera-biopharma-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/statera-biopharma-inc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/statera-biopharma-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/statera-biopharma-inc/embedded-derivative-no-longer-bifurcated-amount-reclassified-to-stockholders-equity https://stock.noler.com/us/stock/statera-biopharma-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/statera-biopharma-inc/eps https://stock.noler.com/us/stock/statera-biopharma-inc/eps-basic https://stock.noler.com/us/stock/statera-biopharma-inc/equity-method-investment-realized-gain-loss-on-disposal https://stock.noler.com/us/stock/statera-biopharma-inc/equity-method-investments https://stock.noler.com/us/stock/statera-biopharma-inc/estimate-of-possible-loss https://stock.noler.com/us/stock/statera-biopharma-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/statera-biopharma-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/statera-biopharma-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/statera-biopharma-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/statera-biopharma-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/statera-biopharma-inc/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/statera-biopharma-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/statera-biopharma-inc/financing-cash-flow https://stock.noler.com/us/stock/statera-biopharma-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/statera-biopharma-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/statera-biopharma-inc/foreign-currency-exchange-rate-translation https://stock.noler.com/us/stock/statera-biopharma-inc/foreign-currency-transaction-gain-before-tax https://stock.noler.com/us/stock/statera-biopharma-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/statera-biopharma-inc/foreign-currency-transaction-gain-loss-realized https://stock.noler.com/us/stock/statera-biopharma-inc/foreign-pretax-income https://stock.noler.com/us/stock/statera-biopharma-inc/form-d-other https://stock.noler.com/us/stock/statera-biopharma-inc/form-d-stocks https://stock.noler.com/us/stock/statera-biopharma-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/statera-biopharma-inc/gain-loss-on-investments https://stock.noler.com/us/stock/statera-biopharma-inc/gain-loss-on-sale-of-investments https://stock.noler.com/us/stock/statera-biopharma-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/statera-biopharma-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/statera-biopharma-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/statera-biopharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/statera-biopharma-inc/goodwill https://stock.noler.com/us/stock/statera-biopharma-inc/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/statera-biopharma-inc/goodwill-gross https://stock.noler.com/us/stock/statera-biopharma-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/statera-biopharma-inc/gross-profit https://stock.noler.com/us/stock/statera-biopharma-inc/held-to-maturity-securities-current https://stock.noler.com/us/stock/statera-biopharma-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/statera-biopharma-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/statera-biopharma-inc/income-loss-from https://stock.noler.com/us/stock/statera-biopharma-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/statera-biopharma-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/statera-biopharma-inc/income-loss-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/statera-biopharma-inc/income-tax https://stock.noler.com/us/stock/statera-biopharma-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/statera-biopharma-inc/income-tax-examination-increase-decrease-in-liability-from-prior-year https://stock.noler.com/us/stock/statera-biopharma-inc/income-tax-examination-liability-refund-adjustment-from-settlement-with-taxing-authority https://stock.noler.com/us/stock/statera-biopharma-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/statera-biopharma-inc/income-tax-examination-penalties-and-interest-expense https://stock.noler.com/us/stock/statera-biopharma-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/statera-biopharma-inc/income-taxes-paid https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-contract-with-customer-asset https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-deposits https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-due-from-related-parties-current https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-fair-value-of-unhedged-derivative-instruments https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/statera-biopharma-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/statera-biopharma-inc/increase-in-restricted-cash https://stock.noler.com/us/stock/statera-biopharma-inc/insider-transactions-preferred https://stock.noler.com/us/stock/statera-biopharma-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/statera-biopharma-inc/insider-transactions-warrants https://stock.noler.com/us/stock/statera-biopharma-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/statera-biopharma-inc/interest-expense-lessee-assets-under-capital-lease https://stock.noler.com/us/stock/statera-biopharma-inc/interest-expense-on-debt https://stock.noler.com/us/stock/statera-biopharma-inc/interest-paid https://stock.noler.com/us/stock/statera-biopharma-inc/interest-paid-net https://stock.noler.com/us/stock/statera-biopharma-inc/investing-cash-flow https://stock.noler.com/us/stock/statera-biopharma-inc/investment-income-interest https://stock.noler.com/us/stock/statera-biopharma-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/statera-biopharma-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/statera-biopharma-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/statera-biopharma-inc/lease-and-rental-expense https://stock.noler.com/us/stock/statera-biopharma-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/statera-biopharma-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/statera-biopharma-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/statera-biopharma-inc/liabilities-noncurrent https://stock.noler.com/us/stock/statera-biopharma-inc/liabilities-of-disposal-group-including-discontinued-operation-noncurrent https://stock.noler.com/us/stock/statera-biopharma-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/statera-biopharma-inc/long-term-notes-payable https://stock.noler.com/us/stock/statera-biopharma-inc/loss-in-period https://stock.noler.com/us/stock/statera-biopharma-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/statera-biopharma-inc/minority-interest https://stock.noler.com/us/stock/statera-biopharma-inc/minority-interest-ownership-percentage-by-noncontrolling-owners https://stock.noler.com/us/stock/statera-biopharma-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/statera-biopharma-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/statera-biopharma-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/statera-biopharma-inc/net-change-in-cash https://stock.noler.com/us/stock/statera-biopharma-inc/net-income https://stock.noler.com/us/stock/statera-biopharma-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/statera-biopharma-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/statera-biopharma-inc/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/statera-biopharma-inc/noncontrolling-interest-decrease-from-deconsolidation https://stock.noler.com/us/stock/statera-biopharma-inc/noncontrolling-interest-increase-from-subsidiary-equity-issuance https://stock.noler.com/us/stock/statera-biopharma-inc/noninterest-expense-offering-cost https://stock.noler.com/us/stock/statera-biopharma-inc/notes-payable-current https://stock.noler.com/us/stock/statera-biopharma-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/statera-biopharma-inc/oci-before-reclassifications-net-of-tax https://stock.noler.com/us/stock/statera-biopharma-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/statera-biopharma-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/statera-biopharma-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/statera-biopharma-inc/oci-foreign-currency-transaction-and-translation-reclassification-adjustment-from-aoci-realized-upon-sale-or-liquidation-net-of-tax https://stock.noler.com/us/stock/statera-biopharma-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/statera-biopharma-inc/operating-cash-flow https://stock.noler.com/us/stock/statera-biopharma-inc/operating-expenses https://stock.noler.com/us/stock/statera-biopharma-inc/operating-income https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-assets https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-expense https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-liability https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-liability-current https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/statera-biopharma-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/statera-biopharma-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/statera-biopharma-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/statera-biopharma-inc/other-assets-miscellaneous-current https://stock.noler.com/us/stock/statera-biopharma-inc/other-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/statera-biopharma-inc/other-current-assets https://stock.noler.com/us/stock/statera-biopharma-inc/other-depreciation-and-amortization https://stock.noler.com/us/stock/statera-biopharma-inc/other-income https://stock.noler.com/us/stock/statera-biopharma-inc/other-income-2 https://stock.noler.com/us/stock/statera-biopharma-inc/other-noncurrent-assets https://stock.noler.com/us/stock/statera-biopharma-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/statera-biopharma-inc/other-nonoperating-expense https://stock.noler.com/us/stock/statera-biopharma-inc/other-nonoperating-income https://stock.noler.com/us/stock/statera-biopharma-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/statera-biopharma-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/statera-biopharma-inc/other-significant-noncash-transaction-value-of-consideration-given https://stock.noler.com/us/stock/statera-biopharma-inc/paid-in-capital-reallocation-of-minority-interest https://stock.noler.com/us/stock/statera-biopharma-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/statera-biopharma-inc/paid-in-capital-shares-issued-ownshare-lending-arrangement-issuance-costs https://stock.noler.com/us/stock/statera-biopharma-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/statera-biopharma-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/statera-biopharma-inc/paid-in-kind-interest https://stock.noler.com/us/stock/statera-biopharma-inc/patents-pending https://stock.noler.com/us/stock/statera-biopharma-inc/payments-of-derivative-issuance-costs https://stock.noler.com/us/stock/statera-biopharma-inc/payments-of-dividends-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/statera-biopharma-inc/payments-of-financing-costs https://stock.noler.com/us/stock/statera-biopharma-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/statera-biopharma-inc/payments-to-acquire-held-to-maturity-securities https://stock.noler.com/us/stock/statera-biopharma-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/statera-biopharma-inc/payments-to-acquire-interest-in-subsidiaries-and-affiliates https://stock.noler.com/us/stock/statera-biopharma-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/statera-biopharma-inc/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/statera-biopharma-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/statera-biopharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/statera-biopharma-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/statera-biopharma-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/statera-biopharma-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/statera-biopharma-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/statera-biopharma-inc/preferred-stock-value https://stock.noler.com/us/stock/statera-biopharma-inc/prepaid-expense-current https://stock.noler.com/us/stock/statera-biopharma-inc/prepaid-insurance https://stock.noler.com/us/stock/statera-biopharma-inc/pretax-income-domestic https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-derivative-instrument-financing-activities https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-divestiture-of-businesses https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-issuance-of-secured-debt https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-minority-shareholders https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-repayments-of-long-term-debt-and-capital-securities https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-sale-of-held-to-maturity-securities https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-sale-of-machinery-and-equipment https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-sale-of-treasury-stock https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/statera-biopharma-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/statera-biopharma-inc/profit-loss https://stock.noler.com/us/stock/statera-biopharma-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/statera-biopharma-inc/property-plant-equipment https://stock.noler.com/us/stock/statera-biopharma-inc/provision-for-other-losses https://stock.noler.com/us/stock/statera-biopharma-inc/public-float https://stock.noler.com/us/stock/statera-biopharma-inc/purchase-obligations-balance-sheet-amount https://stock.noler.com/us/stock/statera-biopharma-inc/reclassification-from-accumulated-oci-current-period-net-of-tax https://stock.noler.com/us/stock/statera-biopharma-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/statera-biopharma-inc/repayments-of-long-term-debt-and-capital-securities https://stock.noler.com/us/stock/statera-biopharma-inc/research-and-development https://stock.noler.com/us/stock/statera-biopharma-inc/restricted-cash https://stock.noler.com/us/stock/statera-biopharma-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/statera-biopharma-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/statera-biopharma-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/statera-biopharma-inc/restricted-cash-and-investments-current https://stock.noler.com/us/stock/statera-biopharma-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/statera-biopharma-inc/restricted-investments-current https://stock.noler.com/us/stock/statera-biopharma-inc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/statera-biopharma-inc/restructuring-reserve https://stock.noler.com/us/stock/statera-biopharma-inc/retained-earnings https://stock.noler.com/us/stock/statera-biopharma-inc/revenue https://stock.noler.com/us/stock/statera-biopharma-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/statera-biopharma-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/statera-biopharma-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/statera-biopharma-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/statera-biopharma-inc/sales-revenue-net https://stock.noler.com/us/stock/statera-biopharma-inc/sales-revenue-services-net https://stock.noler.com/us/stock/statera-biopharma-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/statera-biopharma-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-10-k https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-10-q https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-10ksb https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-10qsb https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-25 https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-25-nse https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-425 https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-8-k https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-ars https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-certbse https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-ct-order https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-def-14a https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-defa14a https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-defr14a https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-regdex https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-s-4 https://stock.noler.com/us/stock/statera-biopharma-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/statera-biopharma-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/statera-biopharma-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/statera-biopharma-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/statera-biopharma-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/statera-biopharma-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/statera-biopharma-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/statera-biopharma-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/statera-biopharma-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/statera-biopharma-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/statera-biopharma-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/statera-biopharma-inc/secured-debt https://stock.noler.com/us/stock/statera-biopharma-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/statera-biopharma-inc/sga-expense https://stock.noler.com/us/stock/statera-biopharma-inc/share-price https://stock.noler.com/us/stock/statera-biopharma-inc/shareholders-equity https://stock.noler.com/us/stock/statera-biopharma-inc/shares-authorized https://stock.noler.com/us/stock/statera-biopharma-inc/shares-issued https://stock.noler.com/us/stock/statera-biopharma-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/statera-biopharma-inc/shares-issued-shares-share-based-compensation-forfeited https://stock.noler.com/us/stock/statera-biopharma-inc/shares-repurchased https://stock.noler.com/us/stock/statera-biopharma-inc/short-term-investments https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-discount-from-market-price-offering-date https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-maximum-number-of-shares-per-employee https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/statera-biopharma-inc/stock-award-shares-issued-in-period https://stock.noler.com/us/stock/statera-biopharma-inc/stock-based-compensation https://stock.noler.com/us/stock/statera-biopharma-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/statera-biopharma-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/statera-biopharma-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/statera-biopharma-inc/stock-issued-shares-issued-shares-treasury-stock-reissued https://stock.noler.com/us/stock/statera-biopharma-inc/stock-issued-shares-issued-value-conversion-of-units https://stock.noler.com/us/stock/statera-biopharma-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/statera-biopharma-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/statera-biopharma-inc/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/statera-biopharma-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/statera-biopharma-inc/stock-issued-shares-issued-value-treasury-stock-reissued https://stock.noler.com/us/stock/statera-biopharma-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-nonvested-options-forfeited-grant-date-fair-value https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-vested-in-period-fair-value-1 https://stock.noler.com/us/stock/statera-biopharma-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/statera-biopharma-inc/stock-split-ratio https://stock.noler.com/us/stock/statera-biopharma-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/statera-biopharma-inc/subsidiary-or-equity-method-investee-cumulative-percentage-ownership-after-all-transactions https://stock.noler.com/us/stock/statera-biopharma-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/statera-biopharma-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/statera-biopharma-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/statera-biopharma-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/statera-biopharma-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/statera-biopharma-inc/tax-reconciliation-deductions-other https://stock.noler.com/us/stock/statera-biopharma-inc/tax-reconciliation-disposition-of-assets https://stock.noler.com/us/stock/statera-biopharma-inc/tax-reconciliation-equity-in-earnings-losses-of-unconsolidated-subsidiary https://stock.noler.com/us/stock/statera-biopharma-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/statera-biopharma-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/statera-biopharma-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/statera-biopharma-inc/total-assets https://stock.noler.com/us/stock/statera-biopharma-inc/total-liabilities https://stock.noler.com/us/stock/statera-biopharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/statera-biopharma-inc/total-long-term-debt https://stock.noler.com/us/stock/statera-biopharma-inc/treasury-stock-shares https://stock.noler.com/us/stock/statera-biopharma-inc/treasury-stock-value https://stock.noler.com/us/stock/statera-biopharma-inc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/statera-biopharma-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/statera-biopharma-inc/utb-change https://stock.noler.com/us/stock/statera-biopharma-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/statera-biopharma-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/statera-biopharma-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/statera-biopharma-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/statera-biopharma-inc/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/statera-biopharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/statera-biopharma-inc/write-off-of-deferred-debt-issuance-cost